Willingdon Wealth Management’s Biogen BIIB Stock Holding History

Willingdon Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.17M	Hold	3,690	–	–	0.29%	77
2019 Q4	$1.09M	Sell	3,690 -246	-6%	-$68.3K	0.23%	91
2019 Q3	$916K	Buy	3,936 +6	+0.2%	+$1.4K	0.2%	94
2019 Q2	$919K	Hold	3,930	–	–	0.21%	95
2019 Q1	$929K	Hold	3,930	–	–	0.23%	96
2018 Q4	$1.18M	Buy	3,930 +3,800	+2,923%	+$1.21M	0.34%	97
2018 Q3	$46K	Hold	130	–	–	0.01%	210
2018 Q2	$38K	Hold	130	–	–	0.01%	196
2018 Q1	$36K	Hold	130	–	–	0.01%	182
2017 Q4	$41K	Hold	130	–	–	0.01%	163
2017 Q3	$41K	Buy	+130	New	+$38.5K	0.01%	161

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Willingdon Wealth Management's BIIB Position: Q1 2020 in Review

Willingdon Wealth Management held its Biogen (BIIB) position steady in Q1 2020 at 3,690 shares worth $1.17M. The position accounts for 0.29% of the portfolio, ranked #77.

Willingdon Wealth Management first reported a position in BIIB in Q3 2017 and has held it in 11 quarters since. The position peaked at $1.18M in Q4 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

Willingdon Wealth Management held 3,690 shares of Biogen worth $1.17M as of Q1 2020.
Willingdon Wealth Management left its Biogen share count unchanged in Q1 2020.
Biogen made up 0.29% of Willingdon Wealth Management's portfolio in Q1 2020, its #77 holding.
Willingdon Wealth Management first reported a position in Biogen in Q3 2017 and has held it in 11 quarters since.
Willingdon Wealth Management's Biogen position peaked at $1.18M in Q4 2018.
1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.